ID   FUT8_HUMAN              Reviewed;         575 AA.
AC   Q9BYC5; B4DFS7; G3V5N0; O00235; Q8IUA5; Q9BYC6; Q9P2U5; Q9P2U6;
DT   05-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   05-MAR-2002, sequence version 2.
DT   10-MAY-2017, entry version 161.
DE   RecName: Full=Alpha-(1,6)-fucosyltransferase;
DE            Short=Alpha1-6FucT;
DE            EC=2.4.1.68;
DE   AltName: Full=Fucosyltransferase 8;
DE   AltName: Full=GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase;
DE   AltName: Full=GDP-fucose--glycoprotein fucosyltransferase;
DE   AltName: Full=Glycoprotein 6-alpha-L-fucosyltransferase;
GN   Name=FUT8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RX   PubMed=9133635; DOI=10.1093/oxfordjournals.jbchem.a021631;
RA   Yanagidani S., Uozumi N., Ihara Y., Miyoshi E., Yamaguchi N.,
RA   Taniguchi N.;
RT   "Purification and cDNA cloning of GDP-L-Fuc:N-acetyl-beta-D-
RT   glucosaminide:alpha1-6 fucosyltransferase (alpha1-6 FucT) from human
RT   gastric cancer MKN45 cells.";
RL   J. Biochem. 121:626-632(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Embryo;
RA   Cailleau A., Balanzino L., Candelier J.J., Oriol R., Mollicone R.;
RT   "Differential splice variants of human FUT8 embryonic cDNA.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=10814706; DOI=10.1093/glycob/10.6.637;
RA   Yamaguchi Y., Ikeda Y., Takahashi T., Ihara H., Tanaka T., Sasho C.,
RA   Uozumi N., Yanagidani S., Inoue S., Fujii J., Taniguchi N.;
RT   "Genomic structure and promoter analysis of the human alpha1,6-
RT   fucosyltransferase gene (FUT8).";
RL   Glycobiology 10:637-643(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), AND ALTERNATIVE SPLICING.
RC   TISSUE=Embryo;
RX   PubMed=14514715; DOI=10.1093/glycob/cwh006;
RA   Martinez-Duncker I., Michalski J.C., Bauvy C., Candelier J.J.,
RA   Mennesson B., Codogno P., Oriol R., Mollicone R.;
RT   "Activity and tissue distribution of splice variants of alpha6-
RT   fucosyltransferase in human embryogenesis.";
RL   Glycobiology 14:13-25(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   DONOR SUBSTRATE-BINDING, AND MUTAGENESIS OF ARG-365 AND ARG-366.
RX   PubMed=10764839; DOI=10.1093/glycob/10.5.503;
RA   Takahashi T., Ikeda Y., Tateishi A., Yamaguchi Y., Ishikawa M.,
RA   Taniguchi N.;
RT   "A sequence motif involved in the donor substrate binding by alpha1,6-
RT   fucosyltransferase: the role of the conserved arginine residues.";
RL   Glycobiology 10:503-510(2000).
RN   [9]
RP   PHOSPHORYLATION.
RX   PubMed=25171405; DOI=10.1016/j.cell.2014.06.048;
RA   Bordoli M.R., Yum J., Breitkopf S.B., Thon J.N., Italiano J.E. Jr.,
RA   Xiao J., Worby C., Wong S.K., Lin G., Edenius M., Keller T.L.,
RA   Asara J.M., Dixon J.E., Yeo C.Y., Whitman M.;
RT   "A secreted tyrosine kinase acts in the extracellular environment.";
RL   Cell 158:1033-1044(2014).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.61 ANGSTROMS) OF 68-575, FUNCTION, CATALYTIC
RP   ACTIVITY, DISULFIDE BOND, AND MUTAGENESIS OF ARG-365; ASP-368;
RP   LYS-369; GLU-373; TYR-382; ASP-409; ASP-410; ASP-453 AND SER-469.
RX   PubMed=17172260; DOI=10.1093/glycob/cwl079;
RA   Ihara H., Ikeda Y., Toma S., Wang X., Suzuki T., Gu J., Miyoshi E.,
RA   Tsukihara T., Honke K., Matsumoto A., Nakagawa A., Taniguchi N.;
RT   "Crystal structure of mammalian alpha1,6-fucosyltransferase, FUT8.";
RL   Glycobiology 17:455-466(2007).
CC   -!- FUNCTION: Catalyzes the addition of fucose in alpha 1-6 linkage to
CC       the first GlcNAc residue, next to the peptide chains in N-glycans.
CC       {ECO:0000269|PubMed:17172260, ECO:0000269|PubMed:9133635}.
CC   -!- CATALYTIC ACTIVITY: GDP-beta-L-fucose + N(4)-(N-acetyl-beta-D-
CC       glucosaminyl-(1->2)-alpha-D-mannosyl-(1->3)-(N-acetyl-beta-D-
CC       glucosaminyl-(1->2)-alpha-D-mannosyl-(1->6))-beta-D-mannosyl-
CC       (1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-
CC       glucosaminyl)asparagine = GDP + N(4)-(N-acetyl-beta-D-
CC       glucosaminyl-(1->2)-alpha-D-mannosyl-(1->3)-(N-acetyl-beta-D-
CC       glucosaminyl-(1->2)-alpha-D-mannosyl-(1->6))-beta-D-mannosyl-
CC       (1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-(alpha-L-fucosyl-
CC       (1->6))-N-acetyl-beta-D-glucosaminyl)asparagine.
CC       {ECO:0000269|PubMed:17172260}.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane
CC       {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}.
CC       Note=Membrane-bound form in trans cisternae of Golgi.
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9BYC5-1; Sequence=Displayed;
CC       Name=2; Synonyms=Retinal;
CC         IsoId=Q9BYC5-2; Sequence=VSP_001807, VSP_001808;
CC       Name=3;
CC         IsoId=Q9BYC5-3; Sequence=VSP_046837;
CC       Name=4; Synonyms=Retina-1, Retina-2;
CC         IsoId=Q9BYC5-4; Sequence=VSP_053361, VSP_053362;
CC         Note=Seems to be only expressed in retina, inactive as a
CC         fucosyltransferase.;
CC   -!- PTM: Tyrosine phosphorylated by PKDCC/VLK.
CC       {ECO:0000269|PubMed:25171405}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 23 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00992}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Fucosyltransferase 8;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_605";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FUT8ID40649ch14q23.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D89289; BAA19764.1; -; mRNA.
DR   EMBL; AH005745; AAB92372.2; -; Genomic_DNA.
DR   EMBL; Y17979; CAA76988.1; -; mRNA.
DR   EMBL; Y17976; CAA76985.1; -; mRNA.
DR   EMBL; Y17977; CAA76986.1; -; mRNA.
DR   EMBL; Y17978; CAA76987.1; -; mRNA.
DR   EMBL; AB049828; BAB40975.1; -; Genomic_DNA.
DR   EMBL; AB049740; BAB40929.2; -; mRNA.
DR   EMBL; AB032573; BAA92859.2; -; Genomic_DNA.
DR   EMBL; AB032573; BAA92858.1; -; Genomic_DNA.
DR   EMBL; AJ514324; CAD55804.1; -; mRNA.
DR   EMBL; AJ514325; CAD55805.1; -; mRNA.
DR   EMBL; AK294242; BAG57538.1; -; mRNA.
DR   EMBL; AL109847; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL161871; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355840; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL359236; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC093889; AAH93889.1; -; mRNA.
DR   EMBL; BC101816; AAI01817.1; -; mRNA.
DR   CCDS; CCDS9775.1; -. [Q9BYC5-1]
DR   CCDS; CCDS9776.2; -. [Q9BYC5-3]
DR   PIR; JC5432; JC5432.
DR   RefSeq; NP_004471.4; NM_004480.4. [Q9BYC5-3]
DR   RefSeq; NP_835368.1; NM_178155.2. [Q9BYC5-1]
DR   RefSeq; NP_835369.1; NM_178156.2. [Q9BYC5-1]
DR   UniGene; Hs.597649; -.
DR   UniGene; Hs.654961; -.
DR   PDB; 2DE0; X-ray; 2.61 A; X=68-575.
DR   PDBsum; 2DE0; -.
DR   ProteinModelPortal; Q9BYC5; -.
DR   SMR; Q9BYC5; -.
DR   BioGrid; 108806; 29.
DR   IntAct; Q9BYC5; 3.
DR   STRING; 9606.ENSP00000353910; -.
DR   ChEMBL; CHEMBL3596087; -.
DR   CAZy; GT23; Glycosyltransferase Family 23.
DR   iPTMnet; Q9BYC5; -.
DR   PhosphoSitePlus; Q9BYC5; -.
DR   BioMuta; FUT8; -.
DR   DMDM; 20138326; -.
DR   EPD; Q9BYC5; -.
DR   MaxQB; Q9BYC5; -.
DR   PaxDb; Q9BYC5; -.
DR   PeptideAtlas; Q9BYC5; -.
DR   PRIDE; Q9BYC5; -.
DR   DNASU; 2530; -.
DR   Ensembl; ENST00000342677; ENSP00000345865; ENSG00000033170. [Q9BYC5-2]
DR   Ensembl; ENST00000360689; ENSP00000353910; ENSG00000033170. [Q9BYC5-1]
DR   Ensembl; ENST00000394586; ENSP00000378087; ENSG00000033170. [Q9BYC5-1]
DR   Ensembl; ENST00000557164; ENSP00000452433; ENSG00000033170. [Q9BYC5-3]
DR   GeneID; 2530; -.
DR   KEGG; hsa:2530; -.
DR   UCSC; uc001xin.3; human. [Q9BYC5-1]
DR   CTD; 2530; -.
DR   DisGeNET; 2530; -.
DR   GeneCards; FUT8; -.
DR   HGNC; HGNC:4019; FUT8.
DR   HPA; CAB017129; -.
DR   HPA; HPA040863; -.
DR   HPA; HPA043410; -.
DR   MIM; 602589; gene.
DR   neXtProt; NX_Q9BYC5; -.
DR   OpenTargets; ENSG00000033170; -.
DR   PharmGKB; PA28435; -.
DR   eggNOG; KOG3705; Eukaryota.
DR   eggNOG; ENOG410YHM8; LUCA.
DR   GeneTree; ENSGT00530000063737; -.
DR   HOGENOM; HOG000204276; -.
DR   HOVERGEN; HBG028260; -.
DR   InParanoid; Q9BYC5; -.
DR   KO; K00717; -.
DR   OMA; NARKLVC; -.
DR   OrthoDB; EOG091G05GD; -.
DR   PhylomeDB; Q9BYC5; -.
DR   TreeFam; TF106108; -.
DR   BRENDA; 2.4.1.68; 2681.
DR   Reactome; R-HSA-975578; Reactions specific to the complex N-glycan synthesis pathway.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; FUT8; human.
DR   EvolutionaryTrace; Q9BYC5; -.
DR   GeneWiki; FUT8; -.
DR   GenomeRNAi; 2530; -.
DR   PRO; PR:Q9BYC5; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000033170; -.
DR   CleanEx; HS_FUT8; -.
DR   ExpressionAtlas; Q9BYC5; baseline and differential.
DR   Genevisible; Q9BYC5; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; NAS:UniProtKB.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0008424; F:glycoprotein 6-alpha-L-fucosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0016477; P:cell migration; IEA:Ensembl.
DR   GO; GO:0046368; P:GDP-L-fucose metabolic process; IDA:UniProtKB.
DR   GO; GO:0001701; P:in utero embryonic development; NAS:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0042355; P:L-fucose catabolic process; NAS:UniProtKB.
DR   GO; GO:0006491; P:N-glycan processing; TAS:UniProtKB.
DR   GO; GO:0009312; P:oligosaccharide biosynthetic process; TAS:ProtInc.
DR   GO; GO:0033578; P:protein glycosylation in Golgi; IEA:InterPro.
DR   GO; GO:0006487; P:protein N-linked glycosylation; TAS:ProtInc.
DR   GO; GO:0018279; P:protein N-linked glycosylation via asparagine; IDA:UniProtKB.
DR   GO; GO:0043112; P:receptor metabolic process; IEA:Ensembl.
DR   GO; GO:1900407; P:regulation of cellular response to oxidative stress; IEA:Ensembl.
DR   GO; GO:0010468; P:regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
DR   InterPro; IPR015827; Alpha1_6FUT_euk.
DR   InterPro; IPR027350; GT23_dom.
DR   InterPro; IPR001452; SH3_domain.
DR   Pfam; PF14604; SH3_9; 1.
DR   PIRSF; PIRSF000472; Alpha1_6FUT_euk; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS51659; GT23; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Disulfide bond;
KW   Glycosyltransferase; Golgi apparatus; Membrane; Phosphoprotein;
KW   Polymorphism; Reference proteome; SH3 domain; SH3-binding;
KW   Signal-anchor; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    575       Alpha-(1,6)-fucosyltransferase.
FT                                /FTId=PRO_0000080526.
FT   TOPO_DOM      1      9       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     10     30       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     31    575       Lumenal. {ECO:0000255}.
FT   DOMAIN      206    493       GT23. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00992}.
FT   DOMAIN      502    563       SH3.
FT   REGION      365    366       Important for donor substrate binding.
FT   MOTIF       299    305       SH3-binding. {ECO:0000255}.
FT   MOD_RES     278    278       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9WTS2}.
FT   DISULFID    204    266       {ECO:0000269|PubMed:17172260}.
FT   DISULFID    212    230       {ECO:0000269|PubMed:17172260}.
FT   DISULFID    218    222       {ECO:0000269|PubMed:17172260}.
FT   DISULFID    465    472       {ECO:0000269|PubMed:17172260}.
FT   VAR_SEQ       1    163       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046837.
FT   VAR_SEQ       1     14       MRPWTGSWRWIMLI -> MHRQIWHLHWTLVR (in
FT                                isoform 4). {ECO:0000303|PubMed:14514715,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_053361.
FT   VAR_SEQ      15    420       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14514715,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_053362.
FT   VAR_SEQ     280    329       EVKDKNVQVVELPIVDSLHPRPPYLPLAVPEDLADRLVRVH
FT                                GDPAVWWVS -> TPIMNLLVITLFPGQLDCTIDTQKIHFV
FT                                E (in isoform 2).
FT                                {ECO:0000303|PubMed:10814706}.
FT                                /FTId=VSP_001807.
FT   VAR_SEQ     330    575       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10814706}.
FT                                /FTId=VSP_001808.
FT   VARIANT     101    101       K -> Q (in dbSNP:rs2229678).
FT                                /FTId=VAR_054038.
FT   VARIANT     267    267       T -> K (in dbSNP:rs35949016).
FT                                /FTId=VAR_033537.
FT   MUTAGEN     365    365       R->A,K: Complete loss of activity.
FT                                {ECO:0000269|PubMed:10764839,
FT                                ECO:0000269|PubMed:17172260}.
FT   MUTAGEN     366    366       R->A,K: Decreases activity to 3%.
FT                                {ECO:0000269|PubMed:10764839}.
FT   MUTAGEN     368    368       D->A: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:17172260}.
FT   MUTAGEN     369    369       K->A: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:17172260}.
FT   MUTAGEN     373    373       E->A: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:17172260}.
FT   MUTAGEN     382    382       Y->A: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:17172260}.
FT   MUTAGEN     409    409       D->A: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:17172260}.
FT   MUTAGEN     410    410       D->A: No effect on enzyme activity.
FT                                {ECO:0000269|PubMed:17172260}.
FT   MUTAGEN     453    453       D->A: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:17172260}.
FT   MUTAGEN     469    469       S->A: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:17172260}.
FT   CONFLICT    214    214       I -> T (in Ref. 5; BAG57538).
FT                                {ECO:0000305}.
FT   HELIX       110    138       {ECO:0000244|PDB:2DE0}.
FT   HELIX       142    172       {ECO:0000244|PDB:2DE0}.
FT   TURN        173    175       {ECO:0000244|PDB:2DE0}.
FT   HELIX       176    199       {ECO:0000244|PDB:2DE0}.
FT   HELIX       204    206       {ECO:0000244|PDB:2DE0}.
FT   STRAND      209    213       {ECO:0000244|PDB:2DE0}.
FT   HELIX       220    236       {ECO:0000244|PDB:2DE0}.
FT   STRAND      240    244       {ECO:0000244|PDB:2DE0}.
FT   HELIX       255    257       {ECO:0000244|PDB:2DE0}.
FT   HELIX       282    285       {ECO:0000244|PDB:2DE0}.
FT   STRAND      287    291       {ECO:0000244|PDB:2DE0}.
FT   HELIX       294    296       {ECO:0000244|PDB:2DE0}.
FT   HELIX       310    312       {ECO:0000244|PDB:2DE0}.
FT   HELIX       313    319       {ECO:0000244|PDB:2DE0}.
FT   HELIX       323    335       {ECO:0000244|PDB:2DE0}.
FT   HELIX       340    353       {ECO:0000244|PDB:2DE0}.
FT   STRAND      357    364       {ECO:0000244|PDB:2DE0}.
FT   HELIX       379    394       {ECO:0000244|PDB:2DE0}.
FT   STRAND      403    409       {ECO:0000244|PDB:2DE0}.
FT   HELIX       411    420       {ECO:0000244|PDB:2DE0}.
FT   STRAND      424    427       {ECO:0000244|PDB:2DE0}.
FT   HELIX       437    441       {ECO:0000244|PDB:2DE0}.
FT   HELIX       446    459       {ECO:0000244|PDB:2DE0}.
FT   STRAND      460    465       {ECO:0000244|PDB:2DE0}.
FT   HELIX       470    479       {ECO:0000244|PDB:2DE0}.
FT   STRAND      482    484       {ECO:0000244|PDB:2DE0}.
FT   STRAND      490    494       {ECO:0000244|PDB:2DE0}.
FT   STRAND      506    509       {ECO:0000244|PDB:2DE0}.
FT   STRAND      528    534       {ECO:0000244|PDB:2DE0}.
FT   STRAND      536    544       {ECO:0000244|PDB:2DE0}.
FT   TURN        545    547       {ECO:0000244|PDB:2DE0}.
FT   STRAND      550    554       {ECO:0000244|PDB:2DE0}.
FT   HELIX       555    557       {ECO:0000244|PDB:2DE0}.
FT   STRAND      558    560       {ECO:0000244|PDB:2DE0}.
SQ   SEQUENCE   575 AA;  66516 MW;  5AE24A93881E18D0 CRC64;
     MRPWTGSWRW IMLILFAWGT LLFYIGGHLV RDNDHPDHSS RELSKILAKL ERLKQQNEDL
     RRMAESLRIP EGPIDQGPAI GRVRVLEEQL VKAKEQIENY KKQTRNGLGK DHEILRRRIE
     NGAKELWFFL QSELKKLKNL EGNELQRHAD EFLLDLGHHE RSIMTDLYYL SQTDGAGDWR
     EKEAKDLTEL VQRRITYLQN PKDCSKAKKL VCNINKGCGY GCQLHHVVYC FMIAYGTQRT
     LILESQNWRY ATGGWETVFR PVSETCTDRS GISTGHWSGE VKDKNVQVVE LPIVDSLHPR
     PPYLPLAVPE DLADRLVRVH GDPAVWWVSQ FVKYLIRPQP WLEKEIEEAT KKLGFKHPVI
     GVHVRRTDKV GTEAAFHPIE EYMVHVEEHF QLLARRMQVD KKRVYLATDD PSLLKEAKTK
     YPNYEFISDN SISWSAGLHN RYTENSLRGV ILDIHFLSQA DFLVCTFSSQ VCRVAYEIMQ
     TLHPDASANF HSLDDIYYFG GQNAHNQIAI YAHQPRTADE IPMEPGDIIG VAGNHWDGYS
     KGVNRKLGRT GLYPSYKVRE KIETVKYPTY PEAEK
//
